InsiderTrades

Form 4 for VRTX Vertex Pharmaceuticals

Accepted 2023-01-31 00:00:00 ET · period of report 2023-01-27 · accession 0001209191-23-005712 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-01-31 2023-01-27 VRTX Lee Yuchun Dir S - Sale+OE $322.03 -1,429 1,875 -43% -$460.2K
D 2023-01-31 2023-01-27 VRTX Lee Yuchun Dir M - OptEx $72.14 +1,429 3,304 +76% +$103.1K
D 2023-01-31 2023-01-27 VRTX Lee Yuchun Dir M - OptEx $0.00 -1,429 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-01-27 S D 970 $322.20 1,955 D — — (F4) Open market sales reported on this line occurred at a weighted average price of $322.20 (range $321.75 to $322.74). (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
2 Common Common Stock 2023-01-27 S D 379 $321.31 2,925 D — — (F3) Open market sales reported on this line occurred at a weighted average price of $321.31 (range $320.62 to $321.59). (F2) Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
3 Common Common Stock 2023-01-27 S D 80 $323.33 1,875 D — —
4 Common Common Stock 2023-01-27 M A 1,429 $72.14 3,304 D — —
5 Derivative Stock Option (Right to Buy) 2023-01-27 M D 1,429 $0.00 0 D $72.14 · — to 2024-05-31 1,429 Common Stock (F5) Fully vested.